Cooperating Oncogenic Events in Murine Mammary Tumorigenesis: Assessment of ErbB2, Mutant p53, and Mouse Mammary Tumor Virus

By Zelazny E.   Li B.   Anagnostopoulos A.-M.   Coleman A.   Perkins A.S.  

Experimental and Molecular Pathology, Vol. 70, Iss. 3, 2001-06 ,pp. : 183-193

Elsevier

Access to resources Recommend Favorite

A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements

By Kimura Mikihiko  

Virchows Archiv, Vol. 445, Iss. 3, 2004-09 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia

By Kasimir-Bauer S.   Beelen D.   Flasshove M.   Noppeney R.   Seeber S.   Scheulen M.E.  

Experimental Hematology, Vol. 30, Iss. 11, 2002-11 ,pp. : 1302-1308

Elsevier

Access to resources Recommend Favorite

Immunohistochemical expression of p53, Bcl-2, Bax, and Fas proteins in squamous cell carcinomas from immunosuppressed renal transplant recipients and immunocompetent individuals

By Seckin D.   Demirhan B.   Karakayali H.   Akgun S.   Erdal R.   Turan M.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2139-2140

Elsevier

Access to resources Recommend Favorite

Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins

By Debnath Irina   Roundy Kirstin M.   Pioli Peter D.   Weis Janis J.   Weis John H.  

International Immunology, Vol. 25, Iss. 2, 2013-02 ,pp. : 99-115

Oxford University Press

Access to resources Recommend Favorite